Proarrhythmic actions of flecainide in an isolated tissue model of ischemia and reperfusion

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 317-324

  Heisler, Benjamin E ^a   Ferrier, Gregory R ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; EXTRASYSTOLE; HEART CONDUCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART MUSCLE REPERFUSION; HEART VENTRICLE TACHYCARDIA; MALE; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; FLECAINIDE; GUINEA PIGS; HEART CONDUCTION SYSTEM; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL;

EID: 0030434256     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. AMSTERDAM, E. A. AND MASON, D. T.: Coronary spasm: Old problem, new questions. Am. Heart J. 101: 242-243, 1981.
2. BENNETT, B. AND SINGH, S.: Management of ventricular arrhythmias: Then and now. Am. J. Crit. Care 1: 107-114, 1992.
3. BRUGADA, J., BOERSMA, L., KIRCHHOF, C. AND ALLESSIE, M.: Proarrhythmic effects of flecainide. Circulation 84: 1808-1818, 1991.
4. CARDIAC ARRHYTHMIA SUPPRESSION TRIAL (CAST) INVESTIGATORS: Preliminary report: Effect of encainide and flecainide on mortality in randomized trial of arrhythmia suppression after myocardial infarction. N. Engl. J. Med. 321: 406-412, 1989.
5. CARDIAC ARRHYTHMIA SUPPRESSION TRIAL II (CAST II) INVESTIGATORS: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N. Engl. J. Med. 327: 227-233, 1991.
6. CORBALAN, R., VERRIER, R. L. AND LOWN, B.: Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Am. Heart J. 92: 223-230, 1976.
7. COROMILAS, J., SALTMAN, A. E., WALDECKER, B., DILLON, S. M. AND WIT, A. L.: Electrophysiological effects of flecainide on anisotropic conduction and reentry in infarcted canine hearts. Circulation 91: 2245-2263, 1995.
8. FALK, R. H.: Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann. Intern. Med. 117: 141-150, 1992.
9. FERRIER, G. R.: Digitalis toxicity. In Electrophysiology and Pharmacology of the Heart, ed. by D. S. Miura and K. H. Dangman, pp. 277-299, Marcel Decker, New York, 1991.
10. FERRIER, G. R. AND GUYETTE, C. M.: Ventricular tachycardia in an isolated guinea pig ventricular free wall model of ischemia and reperfusion. J. Cardiovasc. Pharmacol. 17: 228-238, 1991.
11. FERRIER, G. R., MOFFAT, M. P. AND LUKAS, A.: Possible mechanisms of ventricular arrhythmias elicited by ischemia followed by reperfusion: studies on isolated canine ventricular tissues. Circ. Res. 56: 184-194, 1985.
12. HARRIS, A. S. AN ROJAS, A. G.: The initiation of ventricular fibrillation due to coronary occlusion. Exp. Med. Surg. 1: 105-122, 1943.
13. HARRIS, L., DOWNAR, E., MICKLEBOROUGH, L., SHAIKH, N., PARSON, I., CHEN, T. AND GRAY, G.: Activation sequence of ventricular tachycardia: Endocardial and epicardial mapping studies in the human ventricle. J. Am. Coll. Cardiol. 10: 1040-1047, 1987.
14. JANSE, M. F. AND WIT, A. L.: Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 69: 1049-1169, 1989.
15. JOSEPHSON, M. E. AND GOTTLIEB, C. D.: Ventricular tachycardias associated with coronary artery disease. In Cardiac Electrophysiology; From Cell to Bedside, ed. by D. P. Zipes and J. Jalife, pp. 571-580, W. B. Saunders Co., Philadelphia, 1990.
16. KRISHNAN, S. C. AND ANTZELEVITCH, C.: Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ. Res. 69: 277-291, 1991.
17. KRISHNAN, S. C. AND ANTZELEVITCH, C.: Flecainide induced arrhythmia in canine ventricular epicardium. Circulation. 87: 562-572, 1993.
18. LEDERMAN, S. N., WENGER, T. L., BOLSTER, D. E. AND STRAUSS, H. C.: Effects of flecainide on occlusion and reperfusion arrhythmias in dogs. J. Cardiovasc. Pharmacol. 13: 541-546, 1989.
19. LI, G.-R. AND FERRIER, G. R.: Effects of quinidine on arrhythmias and conduction in an isolated tissue model of ischemia and reperfusion. J. Cardiovasc. Pharmacol. 17: 239-248, 1991a.
20. LI, G.-R. AND FERRIER, G. R.: Effects of lidocaine on reperfusion arrhythmias and electrophysiological properties in an isolated ventricular muscle model of ischemia and reperfusion. J. Pharmacol. Exp. Ther. 257: 997-1004, 1991b.
21. LI, G.-R. AND FERRIER, G. R.: Verapamil prevents slowing of transmural conduction and suppresses arrhythmias in an isolated guinea pig ventricular model of ischemia and reperfusion. Circ. Res. 70: 6510-659, 1992a.
22. LI, G.-R. AND FERRIER, G. R.: Effects of allopurinol on reperfusion arrhythmias in isolated ventricles. Am. J. Physiol. 263: H341-H348, 1992b.
23. 0 acidosis and hypoxia. Jpn. Heart J. 28: 539-554, 1987.
24. MIYAZAKI, T., OGAWA, S., SAKAI, T., HOSOKAWA, M., SAKURAI, K. AND NAKAMURA, Y.: Effects of class I drugs on reentrant ventricular tachycardia in a canine model of myocardial infarction: on their antiarrhythmic and proarrhythmic mechanisms. Jpn. Circ. J. 52: 254-261, 1988.
25. PASNANI, J. S. AND FERRIER, G. R.: Differential effects of glyburide on premature beats and ventricular tachycardia in an isolated tissue model of ischemia and reperfusion. J. Pharmacol. Exp. Ther. 262: 1076-1084, 1992.
26. PASNANI, J. S. AND FERRIER, G. R.: Pro- and antiarrhythmic effects of d-sotalol and dl-sotalol in an isolated tissue model of ischemia and reperfusion. J. Pharmacol. Exp. Ther. 271: 184-192, 1994.
27. POGWIZD, S. M. AND CORR, P. B.: Electrophysiologic mechanisms underlying arrhythmias due to reperfusion of ischemic myocardium. Circulation 76: 404-426, 1987.
28. RANGER S. AND NATTEL S.: Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs. Circulation 92: 1300-1311, 1995.
29. RENTROP, P., BLANKE, H., KARSH, K. R., KAISER, H., KOSTERING, H. AND LEITZ, K.: Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 63: 307-317, 1981.
30. REYNOLDS, J. E. F.: Flecainide acetate. In Martindale: The Extra Pharmacopoeia, 30th ed., ed. by J. E. F. Reynolds, pp. 65-67, The Pharmaceutical Press, London, England, 1993.
31. RODEN, D. M.: Risks and benefits of antiarrhythmic therapy. Drug Ther. 331: 785-791, 1994.
32. SAKAI, T., OGAWA, S., HOSOKAWA, M., MIYAZAKI, T., SAKURAI, K. AND NAKAMURA, Y.: Electrophysiological effects of flecainide in a canine 7 day old myocardial infarction model. Cardiovasc. Res. 23: 177-183, 1989.
33. THOMAS, G. P., HOWLETT, S. E. AND FERRIER, G. R.: Saralasin suppresses arrhythmias in an isolated guinea pig ventricular free wall model of simulated ischemia and reperfusion. J. Pharmacol. Exp. Ther. 274: 1379-1386, 1995.
34. TIMOUR, Q., AUPETIT, J. F., LOUFOUAM, J., GERENTES, I., KIOUEH, I. AND FAUCON, G.: Class Ic antiarrhythmic drugs and myocardial ischemia: study in the pig heart in situ. Naunyn-Schmiedeberg's Arch. Pharmacol. 343: 645-651, 1991.
35. WOOSLEY, R. L. AND FUNCK-BRENTANO, C.: Overview of the clinical pharmacology of antiarrhythmic drugs. Am. J. Cardiol. 61: 61A-69A, 1988.